Literature DB >> 9402289

Effects of different hyaluronidase concentrations and mechanical procedures for cumulus cell removal on the outcome of intracytoplasmic sperm injection.

H Van de Velde1, Z P Nagy, H Joris, A De Vos, A C Van Steirteghem.   

Abstract

The aim of this study was to compare concentrations of hyaluronidase and mechanical methods used to denude human oocytes from surrounding cumulus and corona cells prior to intracytoplasmic sperm injection (ICSI). Cumulus and corona cells were removed in two pipetting steps: first in a medium containing hyaluronidase, and then in a medium without enzyme. The first step in the procedure was investigated. Different hyaluronidase concentrations (78, 39 or 10 IU/ml) and pipettes of different size (inner diameter 250 or > 1000 microm) were used to remove the cumulus cells. The time required to denude the oocytes was recorded. Metaphase II oocytes were injected, and the survival, fertilization, embryo development and pregnancy rates were evaluated. We found that by using a pipette with an inner diameter of at least 1000 microm we were able to decrease significantly the time an oocyte is exposed to hyaluronidase, even if the concentration of enzyme is very low (10 IU/ml). For the different conditions there was no statistically significant effect on the outcome in terms of survival, normal fertilization [two pronuclear (2PN)], parthenogenetic activation (1PN), abnormal fertilization (3PN), embryo development and pregnancy rates after ICSI. In conclusion, a concentration as low as 10 IU/ml hyaluronidase in combination with a pipette of at least 1000 microm inner diameter can be used successfully to denude oocytes for microinjection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402289     DOI: 10.1093/humrep/12.10.2246

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  15 in total

1.  A prospective study on oocyte survival rate after ICSI: influence of injection technique and morphological features.

Authors:  T Ebner; C Yaman; M Moser; M Sommergruber; K Jesacher; G Tews
Journal:  J Assist Reprod Genet       Date:  2001-12       Impact factor: 3.412

Review 2.  Microfluidic Systems for Assisted Reproductive Technologies: Advantages and Potential Applications.

Authors:  Russel C Sequeira; Tracy Criswell; Anthony Atala; James J Yoo
Journal:  Tissue Eng Regen Med       Date:  2020-11-25       Impact factor: 4.169

Review 3.  Application of microfluidic technologies to human assisted reproduction.

Authors:  Gary D Smith; Shuichi Takayama
Journal:  Mol Hum Reprod       Date:  2017-04-01       Impact factor: 4.025

4.  Women with high telomerase activity in luteinised granulosa cells have a higher pregnancy rate during in vitro fertilisation treatment.

Authors:  Hong Chen; Wenjun Wang; Yaqin Mo; Yun Ma; Nengyong Ouyang; Ruiqi Li; Meiqi Mai; Yingming He; M M Abide Bodombossou-Djobo; Dongzi Yang
Journal:  J Assist Reprod Genet       Date:  2011-06-30       Impact factor: 3.412

5.  Late fertilization of unfertilized human oocytes in in vitro fertilization and intracytoplasmic sperm injection cycles: conventional insemination versus ICSI.

Authors:  K S Park; H B Song; S S Chun
Journal:  J Assist Reprod Genet       Date:  2000-09       Impact factor: 3.412

6.  Assisting in vitro fertilization by manipulating cumulus-oocyte-complexes either mechanically or enzymatically does not prevent IVF failure.

Authors:  Thomas Ebner; Marianne Moser; Omar Shebl; Richard Mayer; Gernot Tews
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-09-01

7.  Mammalian oocytes are targets for prostaglandin E2 (PGE2) action.

Authors:  Diane M Duffy; Lynda K McGinnis; Catherine A Vandevoort; Lane K Christenson
Journal:  Reprod Biol Endocrinol       Date:  2010-11-01       Impact factor: 5.211

8.  Developmental stage on day-5 and fragmentation rate on day-3 can influence the implantation potential of top-quality blastocysts in IVF cycles with single embryo transfer.

Authors:  Tiziana della Ragione; Greta Verheyen; Evangelos G Papanikolaou; Lisbet Van Landuyt; Paul Devroey; Andre Van Steirteghem
Journal:  Reprod Biol Endocrinol       Date:  2007-01-26       Impact factor: 5.211

9.  CONCERN: Does ovary need D-chiro-inositol?

Authors:  Rosalbino Isabella; Emanuela Raffone
Journal:  J Ovarian Res       Date:  2012-05-15       Impact factor: 4.234

10.  A case of conjoined twins after a transfer of a multinuclear embryo.

Authors:  Harri Mankonen; Jaana Seikkula; Tuija Järvenpää; Varpu Jokimaa
Journal:  Clin Case Rep       Date:  2015-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.